BriaCell Therapeutics Corp. (TSX:BCT)
6.04
+0.02 (0.33%)
Sep 25, 2026, 3:59 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 52.55 million as of September 25, 2026. Its market cap has increased by 108.64% in one year.
Market Cap
52.55M
Enterprise Value
20.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.04
ChartMarket Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 52.55M, an increase of 115.21%. That is a compound annual growth rate of 6.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 52.55M | 184.62% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 60.78M |
| NurExone Biologic | 59.77M |
| MedMira | 45.61M |
| Sona Nanotech | 43.59M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 41.09M |
| Defence Therapeutics | 37.89M |
| Medicenna Therapeutics | 37.38M |